Cite
HARVARD Citation
Guo, L. et al. (2020). Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology. pp. 192-201. [Online].